Unknown

Dataset Information

0

A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients.

ABSTRACT:

SUBMITTER: Tedeschi A 

PROVIDER: S-EPMC4666341 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
| S-EPMC5278955 | biostudies-literature
Unknown Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study.
| S-EPMC7214269 | biostudies-literature
Unknown Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL).
| S-EPMC3894149 | biostudies-literature
Unknown Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)
| S-EPMC11152604 | biostudies-literature
Unknown Single-agent lenalidomide in the treatment of previously untreated chronic lymphocytic leukemia.
| S-EPMC4874217 | biostudies-literature
Unknown Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study.
| S-EPMC9719965 | biostudies-literature
Unknown Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts.
| S-EPMC3107891 | biostudies-literature
Unknown Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia.
| S-EPMC4705612 | biostudies-literature
Unknown Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective.
| S-EPMC4530370 | biostudies-literature
Unknown Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia.
| S-EPMC6706803 | biostudies-literature